Contra Sage Theraputics
13F holders, Q1 2026 (March 31)4holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Contra Sage Theraputics in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were SouthState Bank Corp ($0), AdvisorShares Investments LLC ($0) and Ascentis Independent Advisors ($0).
- Company
- Contra Sage Theraputics
- CUSIP
- 786CVR019
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 5 shares bought and 338 shares sold, net −333 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| SouthState Bank Corp | 0.00% | No change | 9 | $0 |
| AdvisorShares Investments LLC | 0.00% | No change | 89,780 | $0 |
| Ascentis Independent Advisors | 0.00% | New | 5 | $0 |
| Keating Financial Advisory Services, Inc. | 0.00% | No change | 80 | $0 |
"% of holder's portfolio" is CONTRA SAGE THERAPUTICS's weight in each manager's 13F, not the share of Contra Sage Theraputics the manager owns.